Lowest effective 131I activity for lymph node metastases therapy of differentiated thyroid cancer patients; Dosimetry-based model for estimation

被引：0
|
作者：
Stebner, V. [1 ]
Phaosricharoen, J. [1 ]
Herrmann, K. [1 ]
Jentzen, W. [1 ]
机构：
[1] Univ Duisburg Essen, Fac Med, Dept Nucl Med, Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
E-PW049
引用
收藏
页码：S396 / S396
页数：1
相关论文
共 50 条
  • [1] Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients Dosimetry-based model for estimation
    Jentzen, W.
    Moldovan, A. -S.
    Ruhlmann, M.
    Goerges, R.
    Bockisch, A.
    Rosenbaum-Krumme, S.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 137 - 143
  • [2] Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) : 20N - 22N
  • [3] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [4] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [5] The study of influence factors on 131I treatment of differentiated thyroid carcinoma with lymph node metastases
    Ye, Zhi-Yi
    Wang, Hui
    Fu, Hong-Liang
    Li, Jia-Ning
    Zou, Ren-Jian
    Gu, Zhen-Hui
    Wu, Jing-Chuan
    CLINICAL IMAGING, 2009, 33 (03) : 221 - 225
  • [6] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications
    Piotr Szumowski
    Saeid Abdelrazek
    Dorota Iwanicka
    Małgorzata Mojsak
    Monika Sykała
    Łukasz Żukowski
    Katarzyna Siewko
    Agnieszka Adamska
    Katarzyna Maliszewska
    Anna Popławska-Kita
    Małgorzata Szelachowska
    Adam Krętowski
    Janusz Myśliwiec
    Scientific Reports, 11
  • [7] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications
    Szumowski, Piotr
    Abdelrazek, Saeid
    Iwanicka, Dorota
    Mojsak, Malgorzata
    Sykala, Monika
    Zukowski, Lukasz
    Siewko, Katarzyna
    Adamska, Agnieszka
    Maliszewska, Katarzyna
    Poplawska-Kita, Anna
    Szelachowska, Malgorzata
    Kretowski, Adam
    Mysliwiec, Janusz
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [9] Iodine-131: An Effective Method for Treating Lymph Node Metastases of Differentiated Thyroid Cancer
    He, Ying
    Pan, Ming-zhi
    Huang, Jian-min
    Xie, Peng
    Zhang, Fang
    Wei, Ling-ge
    MEDICAL SCIENCE MONITOR, 2016, 22 : 4924 - 4928
  • [10] Estimation of residual activities in patients with differentiated thyroid cancer after administration of 131I for therapy
    Gao, Y.
    Tang, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S540 - S540
12345